Board meeting on Oct 24, 2026 to approve Q2 and H1 FY27 results

Revenue declinedNegative operating cash flowResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.3%Reaction day

₹2.10

prior close

₹2.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%-1.7% vs market

Trading - Chemicals peers, median of 12sector-2.2%-2.1% vs sector

On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 2.1 pts less than its Trading - Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-1.4

15m

-1.9

30m

-6.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.3-2.6-1.7-2.2-2.1

Next day

-9.0-3.6-5.4-4.1-4.9

-13.3-5.8-7.5-4.7-8.6

-17.6-5.5-12.1-0.7-17.0

-21.4-3.8-17.6-1.3-20.1

-25.2-3.8-21.5-1.0-24.3

-25.2-5.6-19.7-1.2-24.0

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Trading - Chemicals peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Evexia Lifecare has informed BSE that its Board of Directors will meet on Saturday, October 24, 2026, among other matters, to consider and approve the unaudited standalone and consolidated financial results for the quarter and six months ended September 30, 2026. The company has also confirmed that the insider trading window will remain closed until 48 hours after the results are made public.

Likely market impact

Investors should watch for the Q2 and H1 FY27 results on or after October 24, 2026. No financials are disclosed in this advance notice.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹25.02 Cr	₹25.73 Cr	−2.8%
Operating profit	−₹0.43 Cr	₹0.07 Cr	−680.3%
Profit after tax	₹0.23 Cr	₹0.37 Cr	−37.9%
EBITDA margin	-0.3%	0.4%	−0.7 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.